Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T21:30:53.409Z.
Calculation as of: 2026-10-06T21:30:53.409Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6e30e9273cc74abd864e2fca08a62f10ee0154e442432ff18a73c00261064cea
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
Market Cap
$472.23M
EBITDA Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$475.91M
EBITDA Yield
N/A
TTM Avg
25.96%
3Y Avg
19.61%
5Y Avg
19.61%
Market Cap
$483.54M
EBITDA Yield
9.61%
TTM Avg
13.75%
3Y Avg
18.95%
5Y Avg
18.84%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arvinas, Inc. (ARVN) | $471.65M | N/A | N/A | N/A | N/A |
| Cerus Corporation (CERS)vs › | $471.57M | 0.01% | 0.01% | 0.01% | 0.01% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.23M | N/A | N/A | N/A | N/A |
| Alpha Teknova, Inc. (TKNO)vs › | $469.12M | N/A | 0.59% | 0.59% | 0.59% |
| Kamada Ltd. (KMDA)vs › | $467.90M | 9.58% | 10.23% | 10.38% | 8.34% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $475.91M | N/A | 25.96% | 19.61% | 19.61% |
| Sight Sciences, Inc. (SGHT)vs › | $465.75M | N/A | N/A | N/A | N/A |
| Puma Biotechnology, Inc. (PBYI)vs › | $483.54M | 9.61% | 13.75% | 18.95% | 18.84% |
| Evolus, Inc. (EOLS)vs › | $486.01M | N/A | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $452.54M | 4.33% | 6.53% | 7.37% | 6.54% |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
